Article
Decreased risk of developing cancer in subjects carrying SLC52A3 rs13042395 polymorphism: proof from a meta-analysis.
Biomarkers in medicine - 1 Oct 2016
Li Jun, Wang Shilong, Li Man, Xu Hui, Li Dandan, Yin Can, Zhao Jin, Li Feng
Abstract excerpt
AIM: This study aimed to conduct a meta-analysis to explore the association between SLC52A3 rs13042395 polymorphism and cancer risk. MATERIALS & METHODS: A comprehensive literature search was performed to confirm the relationship evaluated using STATA 12.0 software. RESULTS: Overall, SLC52A3 rs13042395 C>T polymorphism was associated with cancer risk in two genetic models (TT vs CC: odds ratio: 0.86; 95% CI:...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
